» Articles » PMID: 2779536

L-propionyl-carnitine Protection of Mitochondria in Ischemic Rat Hearts

Overview
Publisher Springer
Specialty Biochemistry
Date 1989 Jun 24
PMID 2779536
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The energy-linked processes (transmembrane potential and oxidative phosphorylation) resulted in impaired mitochondria isolated from ischemic perfused rat hearts. Addition of 1.5 mM L-propionyl-carnitine to the perfusate significantly reduced the ischemic damage and ameliorated mitochondrial Ca2+ homeostasis. In both normoxic and ischemic hearts perfused with L-propionyl-carnitine a consistent amount of propionyl-CoA-otherwise undetectable-was produced. L-propionyl-carnitine treatment also prevented the decrease of succinyl-CoA associated with the ischemic condition. These results and the decrease of myocardial acetyl-CoA induced by exogenous L-propionyl-carnitine points to the anaplerotic effect of this ester. The consequently improved flux in the tricarboxylic-acid cycle may account for the observed protection of mitochondrial functions afforded by L-propionyl-carnitine in the ischemic perfused hearts.

Citing Articles

Upregulation of Krebs cycle and anaerobic glycolysis activity early after onset of liver ischemia.

Chan T, Cassim S, Raymond V, Gottschalk S, Merlen G, Zwingmann C PLoS One. 2018; 13(6):e0199177.

PMID: 29902244 PMC: 6002017. DOI: 10.1371/journal.pone.0199177.


Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.

Ananthakrishnan R, Kaneko M, Hwang Y, Quadri N, Gomez T, Li Q Am J Physiol Heart Circ Physiol. 2008; 296(2):H333-41.

PMID: 19060123 PMC: 2643894. DOI: 10.1152/ajpheart.01012.2008.


Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective.

Wolff A, Rotmensch H, Stanley W, Ferrari R Heart Fail Rev. 2002; 7(2):187-203.

PMID: 11988642 DOI: 10.1023/a:1015384710373.


Propionyl-L-carnitine effects on postischemic recovery of heart function and substrate oxidation in the diabetic rat.

Broderick T, Driedzic W, Paulson D Mol Cell Biochem. 2000; 206(1-2):151-7.

PMID: 10839205 DOI: 10.1023/a:1007022114594.


Technetium-99m sestamibi leg scintigraphy for non-invasive assessment of propionyl-L-carnitine induced changes in skeletal muscle metabolism.

Cittanti C, Colamussi P, Giganti M, Orlandi C, Uccelli L, Manfrini S Eur J Nucl Med. 1997; 24(7):762-6.

PMID: 9211762 DOI: 10.1007/BF00879664.


References
1.
Liedtke A, Demaison L, Nellis S . Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts. Am J Physiol. 1988; 255(1 Pt 2):H169-76. DOI: 10.1152/ajpheart.1988.255.1.H169. View

2.
Lindenmayer G, SORDAHL L, Schwartz A . Reevaluation of oxidative phosphorylation in cardiac mitochondria from normal animals and animals in heart failure. Circ Res. 1968; 23(3):439-50. DOI: 10.1161/01.res.23.3.439. View

3.
Pontremoli S, Melloni E, Michetti M, Sparatore B, Salamino F, SILIPRANDI N . Isovalerylcarnitine is a specific activator of calpain of human neutrophils. Biochem Biophys Res Commun. 1987; 148(3):1189-95. DOI: 10.1016/s0006-291x(87)80258-9. View

4.
Paulson D, Traxler J, Schmidt M, Noonan J, Shug A . Protection of the ischaemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation. Cardiovasc Res. 1986; 20(7):536-41. DOI: 10.1093/cvr/20.7.536. View

5.
SILIPRANDI N, Siliprandi D, CIMAN M . Stimulation of oxidation of mitochondrial fatty acids and of acetate by acetylcarnitine. Biochem J. 1965; 96(3):777-80. PMC: 1207216. DOI: 10.1042/bj0960777. View